This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a drug used in patients with bleeding disorders. It works by activating molecules in the blood stream called platelets that promote clotting. In the study, participants who are have cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive medication. Photographs taken before and shortly after surgery will be evaluated for the amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not eligible to participate.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
14
Patients Receiving DDAVP prior to operation
Lyndhurst Surgery Center
Lyndhurst, Ohio, United States
Reduction in Ecchymosis and Swelling
Photographs taken preoperatively at 1 day and 8 days post-operatively will be analyzed for bruising
Time frame: surgery to 8 days post-operatively
Patient Behavior Factors
Looking at the time it takes for patients to feel comfortable wearing makeup, going out in public, and returning to work
Time frame: Surgery to 3 weeks post-operatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.